Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic Therapeutics
Pharmaceutical R&D

Eli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic Therapeutics

Teuku Ryan Jul 20, 2026 0

In a landmark move that signals a significant shift in pharmaceutical investment, Eli Lilly and Company has announced the acquisition…

Read More
Data Science & Bioinformatics

The ‘Entry-Level’ Gatekeeper: Auditing Job Descriptions with Textstat for Enhanced Accessibility and Inclusivity.

Evan Lee Salim May 29, 2026 0

The modern recruitment landscape frequently presents a perplexing paradox: "entry-level" job descriptions laden with dense, impenetrable jargon that inadvertently deter…

Read More
Biotech & Genetic Research

University of Minnesota Scientists Uncover Marburg Virus’s Entry Mechanism, Revealing Key Therapeutic Vulnerabilities.

Jia Lissa Mar 20, 2026 0

The highly pathogenic Marburg virus, a formidable global health threat renowned for its severe hemorrhagic fever and an average fatality…

Read More
How breast cancer cells survive in bone marrow after remissionInnovative RNA Barcoding Technology Connectome-seq Maps Thousands of Neural Connections to Unlock Secrets of Brain Circuitry and DiseaseThe Secret Lives of Beluga Whales Unveiled: DNA Study Reveals Remarkable Mating Strategies and Genetic Resilience in Bristol Bay PopulationBreakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Potential Treatment Pathways
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ